Jason is an accomplished start-up founder and executive with experience developing and commercializing disruptive products to solve healthcare‚Äôs most challenging problems. He is currently co-founder, board member and CEO of Endpoint Health, a Precision First therapeutics company dedicated to addressing urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each individual patient‚Äôs biology. Prior to Endpoint Health, co-founded GeneWEAVE, a diagnostics company that developed novel solutions to improve diagnosis and therapy choice in drug-resistant infections. Started in 2010, GeneWEAVE raised $25M in venture financing and was acquired by Roche in 2015. Jason received an MBA from Cornell University and currently lives in San Jose, CA with his wife and daughters.
AI & Data Science Showcase:
Endpoint Health is a precision-first therapeutics company dedicated to addressing urgent needs in immune-driven illnesses by developing therapies that are personalized to each patient‚Äôs biology.
Rewriting the Rules in Precision-First BioPharma
Learn how Endpoint Health is using it's Precision-First AI platform to develop life-changing immunology therapies personalized to each patient‚Äôs biology. Combining therapeutics, diagnostics and AI, the Company is unlocking value for patients, doctors, and healthcare systems.
The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.